BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Clearside Biomedical 

1220 Old Alpharetta Road
Suite 300
Alpharetta   Georgia  30005  U.S.A.
Phone: 678-270-3631 Fax:


SEARCH JOBS


Industry
Pharmaceutical






 Company News
Clearside Biomedical Announces Third Patent Allowance In The U.S. Related To Proprietary Microneedle Drug Delivery Methods And Devices 1/29/2014 9:25:45 AM    More...
Clearside Biomedical Names Glenn Noronha, Ph.D., Executive Vice President, Research and Development 8/5/2013 6:53:52 AM    More...
Clearside Biomedical Announces Appointment of Gerald D. Cagle, Ph.D. to Board of Directors 7/22/2013 6:36:55 AM    More...
Clearside Biomedical to Present Research on Proprietary Retinal Therapeutics Platform at 2013 Association for Research in Vision & Ophthalmology Meeting 5/1/2013 7:42:56 AM    More...
Santen Pharmaceutical and Clearside Biomedical Enter Into Financing and Research Collaboration Agreements for Posterior Ocular Disease 1/31/2013 10:18:08 AM    More...
Clearside Biomedical Announces Plans for Clinical Testing of CLS1001 (Triamcinolone Acetonide) Suprachoroidal Injectable Suspension for the Treatment of Some Eye Diseases 1/10/2013 9:30:39 AM    More...
Clearside Biomedical Names Charles Deignan Chief Financial Officer 10/29/2012 6:29:32 AM    More...

//-->